Literature DB >> 21188623

Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction.

Kristina Gopcevic1, Branislav Rovcanin, Dusan Kekic, Sandra Radenkovic.   

Abstract

Coronary artery disease is a multifunctional disease and represents one of the leading causes of death worldwide. Oxidative stress appears as an etiological factor for myocardial damage during acute myocardial infarction. Some data suggest that acute coronary syndromes may also be influenced by matrix metalloproteinases through degradation of the fibrous cap of vulnerable atherosclerotic lesions. It has been indicated that gelatinases A and B play a key role in acute myocardial infarction and deoxyribonuclease I has been postulated to be a novel early phase marker of disease. The aim was to study activity of gelatinases A and B in acute myocardial infarction and its association with some membrane damage markers. Seventy-five patients with disease and seventy-five healthy controls were enrolled. Activities of lactate dehydrogenase, malate dehydrogenase, and deoxyribonuclease I were estimated using standard spectrophotometric assay and isoforms of lactate and malate dehydrogenases were determined using direct zymography. Activity of dehydrogenases was significantly higher in patients, while deoxyribonuclease I was lower. Isoform 2 of lactate dehydrogenase was significantly higher in the patient group. Gelatinases A and B were detected only in patients group. The results suggest determination of serum malate dehydrogenase activity to be used as an additional parameter for acute myocardial infarction diagnosis. Those findings suggest important role of gelatinases A and B as biomarkers of early stage of acute myocardial infarction together with membrane damage parameters.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21188623     DOI: 10.1007/s11010-010-0694-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  36 in total

1.  Matrix metalloproteinases and cardiovascular disease.

Authors:  Stefan Agewall
Journal:  Eur Heart J       Date:  2005-11-04       Impact factor: 29.983

2.  Ability of DNase I activity to detect myocardial ischaemia in vasospastic angina--a view through a monocle?

Authors:  Evangelos Giannitsis; Hugo A Katus
Journal:  Eur Heart J       Date:  2007-11-06       Impact factor: 29.983

3.  Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.

Authors:  Shin-ichiro Matsumura; Shiro Iwanaga; Satsuki Mochizuki; Hiroyuki Okamoto; Satoshi Ogawa; Yasunori Okada
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

4.  Kinetic studies on pig heart cytoplasmic malate dehydrogenase.

Authors:  C Frieden; J Fernandez-Sousa
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

5.  Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase (MDH1).

Authors:  Agnes Shuk-Yee Lo; Choong-Tsek Liew; Sai-Ming Ngai; Stephen Kwok-Wing Tsui; Kwok-Pui Fung; Cheuk-Yu Lee; Mary Miu-Yee Waye
Journal:  J Cell Biochem       Date:  2005-03-01       Impact factor: 4.429

Review 6.  Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome.

Authors:  Charles B Jones; David C Sane; David M Herrington
Journal:  Cardiovasc Res       Date:  2003-10-01       Impact factor: 10.787

Review 7.  Oxygen radicals and human disease.

Authors:  C E Cross; B Halliwell; E T Borish; W A Pryor; B N Ames; R L Saul; J M McCord; D Harman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

8.  Diagnostic use of serum deoxyribonuclease I activity as a novel early-phase marker in acute myocardial infarction.

Authors:  Yasuyuki Kawai; Masahiro Yoshida; Kenichiro Arakawa; Teruhiko Kumamoto; Norihiro Morikawa; Katsuhiko Masamura; Hiroshi Tada; Sachiko Ito; Hiroshi Hoshizaki; Shigeru Oshima; Koichi Taniguchi; Hidekazu Terasawa; Isamu Miyamori; Koichiro Kishi; Toshihiro Yasuda
Journal:  Circulation       Date:  2004-05-17       Impact factor: 29.690

9.  Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test.

Authors:  Norihiro Morikawa; Yasuyuki Kawai; Kenichiro Arakawa; Teruhiko Kumamoto; Isamu Miyamori; Hironobu Akao; Michihiko Kitayama; Kouji Kajinami; Jong-Dae Lee; Haruo Takeshita; Yoshihiko Kominato; Toshihiro Yasuda
Journal:  Eur Heart J       Date:  2007-10-29       Impact factor: 29.983

10.  [Malate dehydrogenase isoenzymes in myocardial infarction].

Authors:  K Wagenknecht; H Barleben; L Junker; A Guchker; E Schuler; K Vagenknekht; Kh Barleben; L Iunker; A Guchker; E Shiuler
Journal:  Kardiologiia       Date:  1988-11       Impact factor: 0.395

View more
  4 in total

1.  Human umbilical cord mesenchymal stem cells-derived exosomes transfers microRNA-19a to protect cardiomyocytes from acute myocardial infarction by targeting SOX6.

Authors:  Lin Huang; Lu Yang; Yin Ding; Xinghua Jiang; Zhen Xia; Zhigang You
Journal:  Cell Cycle       Date:  2020-01-10       Impact factor: 4.534

2.  Short-term inhalation of cadmium oxide nanoparticles alters pulmonary dynamics associated with lung injury, inflammation, and repair in a mouse model.

Authors:  Jason L Blum; Lauren K Rosenblum; Gabriele Grunig; Mary Beth Beasley; Judy Q Xiong; Judith T Zelikoff
Journal:  Inhal Toxicol       Date:  2014-01       Impact factor: 2.724

3.  Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy.

Authors:  Essa M Essa; Michael R Zile; Robert E Stroud; Allison Rice; Richard J Gumina; Carl V Leier; Francis G Spinale
Journal:  J Card Fail       Date:  2012-06       Impact factor: 5.712

4.  Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction.

Authors:  Li-Ying Shi; Yu-Shuai Han; Jing Chen; Zhi-Bin Li; Ji-Cheng Li; Ting-Ting Jiang
Journal:  Ann Transl Med       Date:  2021-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.